Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'thiotepa' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 185 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Huitema, ADR; Mathot, RAA; Tibben, MM; Rodenhuis, S; Beijnen, JH
      A mechanism-based pharmacokinetic model for the cytochrome P450 drug-drug interaction between cyclophosphamide and thioTEPA and the autoinduction of cyclophosphamide

      JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
    2. Huitema, ADR; Reinders, C; Tibben, MM; Rodenhuis, S; Beijnen, JH
      Sensitive gas chromatographic determination of the cyclophosphamide metabolite 2-dechloroethylcyclophosphamide in human plasma

      JOURNAL OF CHROMATOGRAPHY B
    3. Miyazaki, M; Miyakoshi, S; Kami, M; Mori, M; Kishi, Y; Inagawa, H; Machida, U; Matsumura, T; Kawagoe, S; Ueyama, JI; Morinaga, SI; Matsushita, H; Muto, Y
      Systemic fusariosis after a preparative regimen including thiotepa, VP-16 and busulfan used for blood stem cell transplantation in Hodgkin's disease

      LEUKEMIA & LYMPHOMA
    4. van Maanen, MJ; Huitema, ADR; Rodenhuis, S; Beijnen, JH
      Urinary excretion of thioTEPA and its metabolites in patients treated withhigh-dose cyclophosphamide, thioTEPA and carboplatin

      ANTI-CANCER DRUGS
    5. Alessandrino, EP; Bernasconi, P; Colombo, AA; Caldera, D; Bonfichi, M; Pagnucco, G; Malcovati, L; Varettoni, M; Lazzarino, M; Bernasconi, C
      Thiotepa and fludarabine (TT-FLUDA) as conditioning regimen in poor candidates for conventional allogeneic hemopoietic stem cell transplant

      ANNALS OF HEMATOLOGY
    6. Miyazaki, M; Lin, YW; Okada, M; Hamahata, K; Kubota, M
      Childhood cutaneous natural killer/T-cell lymphoma successfully treated with only one course of chemotherapy and incomplete tumor resection

      HAEMATOLOGICA
    7. Bibawi, S; Abi-Said, D; Fayad, L; Anderlini, P; Ueno, NT; Mehra, R; Khouri, I; Giralt, S; Gajewski, J; Donato, M; Claxton, D; Braunschweig, I; van Besien, K; Andreeff, M; Andersson, BS; Estey, EH; Champlin, R; Przepiorka, D
      Thiotepa, busulfan, and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced myelodysplastic syndrome and acute myelogenous leukemia

      AMERICAN JOURNAL OF HEMATOLOGY
    8. Huitema, ADR; Mathot, RAA; Tibben, MM; Schellens, JHM; Rodenhuis, S; Beijnen, JH
      Population pharmacokinetics of thioTEPA and its active metabolite TEPA in patients undergoing high-dose chemotherapy

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    9. Lichtman, SM; Kolitz, J; Budman, DR; Schulman, P; Vinciguerra, V; Hoffman, M; Mittelman, A; Allen, SL; Fusco, D; Hayes, FA
      Treatment of aggressive non-Hodgkin's lymphoma in elderly patients with thiotepa, novantrone (mitoxantrone), vincristine, prednisone (TNOP)

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    10. Gutierrez-Delgado, F; Maloney, DG; Press, OW; Golden, J; Holmberg, LA; Maziarz, RT; Hooper, H; Buckner, CD; Appelbaum, FR; Bensinger, WI
      Autologous stem cell transplantation for non-Hodgkin's lymphoma: comparison of radiation-based and chemotherapy-only preparative regimens

      BONE MARROW TRANSPLANTATION
    11. Sauerbrey, A; Bielack, S; Kempf-Bielack, B; Zoubek, A; Paulussen, M; Zintl, F
      High-dose chemotherapy (HDC) and autologous hematopoietic stem cell transplantation (ASCT) as salvage therapy for relapsed osteosarcoma

      BONE MARROW TRANSPLANTATION
    12. Hertzberg, H; Kremens, B; Velten, I; Beck, JD; Greil, J
      Recurrent disseminated retinoblastoma in a 7-year-old girl treated successfully by high-dose chemotherapy and CD34-selected autologous peripheral blood stem cell transplantation

      BONE MARROW TRANSPLANTATION
    13. Mileshkin, L; Prince, HM; Rischin, D; Zimet, A
      Severe interstitial pneumonitis following high-dose cyclophosphamide, thiotepa and docetaxel: two case reports and a review of the literature

      BONE MARROW TRANSPLANTATION
    14. Huncharek, M; Mcgarry, R; Kupelnick, B
      Impact of intravesical chemotherapy on recurrence rate of recurrent superficial transitional cell carcinoma of the bladder: Results of a meta-analysis

      ANTICANCER RESEARCH
    15. Huitema, ADR; Mathot, RAA; Tibben, MM; Rodenhuis, S; Beijnen, JH
      Validation of a therapeutic drug monitoring strategy for thiotepa in a high-dose chemotherapy regimen

      THERAPEUTIC DRUG MONITORING
    16. Cokgor, I; Akabani, G; Friedman, HS; Friedman, AH; Zalutsky, MR; Zehngebot, LM; Provenzale, JM; Guy, CD; Wikstrand, CJ; Bigner, DD
      Long term response in a patient with neoplastic meningitis secondary to melanoma treated with I-131-radiolabeled antichondroitin proteoglycan sulfateMel-14 F(ab ')(2) - A case study

      CANCER
    17. Masters, JR
      Re: Methods to improve efficacy of intravesical mitomycin C: Results of a randomized phase III trial

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    18. Rodenhuis, S; Huitema, ADR; van Dam, FSAM; de Vries, EGE; Beijnen, JH
      High-dose chemotherapy with peripheral blood progenitor cell transplantation in the adjuvant treatment of breast cancer

      CANCER JOURNAL
    19. Tudor, G; Aguilera, A; Halverson, DO; Laing, ND; Sausville, EA
      Susceptibility to drug-induced apoptosis correlates with differential modulation of Bad, Bcl-2 and Bcl-x(L) protein levels

      CELL DEATH AND DIFFERENTIATION
    20. Dunkel, IJ
      High-dose chemotherapy with autologous stem cell rescue for malignant brain tumors

      CANCER INVESTIGATION
    21. Patnaik, A; MacKinnon, A; Goss, P; Nagy, T; Stewart, K; Keating, A; Crump, M
      Phase I/II trial of cyclophosphamide, mitoxantrone, and escalated doses ofcarboplatin supported by peripheral-blood stem cells in women with metastatic breast cancer

      JOURNAL OF CLINICAL ONCOLOGY
    22. van Maanen, MJ; Smits, KD; Damen, JMA; Heck, AJR; Beijnen, JH
      Stability of thioTEPA and its metabolites, TEPA, monochloroTEPA and thioTEPA-mercapturate, in plasma and urine

      INTERNATIONAL JOURNAL OF PHARMACEUTICS
    23. Huitema, ADR; Kerbusch, T; Tibben, MM; Rodenhuis, S; Beijnen, JH
      Reduction of cyclophosphamide bioactivation by thioTEPA: critical sequence-dependency in high-dose chemotherapy regimens

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    24. Tetef, ML; Margolin, KA; Doroshow, JH; Akman, S; Leong, LA; Morgan, RJ; Raschko, JW; Slatkin, N; Somlo, G; Longmate, JA; Carroll, MI; Newman, EM
      Pharmacokinetics and toxicity of high-dose intravenous methotrexate in thetreatment of leptomeningeal carcinomatosis

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    25. Frei, E; Ara, G; Teicher, B; Bunnell, C; Richardson, P; Wheeler, C; Tew, K; Elias, A
      Double high-dose chemotherapy with stem cell rescue (HD-SCR) in patients with breast cancer - effect of sequence

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    26. Martinoni, A; Cipolla, CM; Civelli, M; Cardinale, D; Lamantia, G; Colleoni, M; DeBraud, F; Susini, G; Martinelli, G; Goldhirsh, A; Fiorentini, C
      Intrapericardial treatment of neoplastic pericardial effusions

      HERZ
    27. van Maanen, MJ; Smeets, CJM; Beijnen, JH
      Chemistry, pharmacology and pharmacokinetics of N,N ',N ''-triethylenethiophosphoramide (ThioTEPA)

      CANCER TREATMENT REVIEWS
    28. Kier, P; Ruckser, R; Buxhofer, V; Habertheuer, K; Zelenka, P; Tatzreiter, G; Hubl, G; Kittl, E; Hauser, A; Sebesta, C; Hinterberger, W
      High-dose chemotherapy and autologous stem-cell transplantation in breast cancer

      ACTA MEDICA AUSTRIACA
    29. Prince, HM; Rischin, D; Toner, GC; Seymour, JF; Blakey, D; Gates, P; Eerhard, S; Chapple, P; Quinn, M; Brettell, M; Juneja, S; Wolf, M; Januszewicz, EH; Richardson, G; Scarlett, J; Briggs, P
      Repetitive high-dose therapy with cyclophosphamide, thiotepa and docetaxelwith peripheral blood progenitor cell and filgrastim support for metastatic and locally advanced breast cancer: results of a phase I study

      BONE MARROW TRANSPLANTATION
    30. Lafay-Cousin, L; Hartmann, O; Plouvier, P; Mechinaud, F; Boutard, P; Oberlin, O
      High-dose thiotepa and hematopoietic stem cell transplantation in pediatric malignant mesenchymal tumors: a phase II study

      BONE MARROW TRANSPLANTATION
    31. Papadakis, V; Dunkel, IJ; Cramer, LD; Kramer, E; Papadopoulos, E; Goldman, S; Packer, RJ; Willoughby, M; Baker, D; Garvin, J; Strandjord, S; Coccia, P; Kaplan, AM; Klemperer, M; Finlay, JL
      High-dose carmustine, thiotepa and etoposide followed by autologous bone marrow rescue for the treatment of high risk central nervous system tumors

      BONE MARROW TRANSPLANTATION
    32. Lamparelli, T; van Lint, MT; Gualandi, F; Raiola, AM; Barbanti, M; Sacchi, N; Ficai, G; Ghinatti, C; Bregante, S; Berisso, G; Dominietto, A; Di Grazia, C; Bruno, B; Sessarego, M; Casarino, L; Verdiani, S; Bacigalupo, A
      Alternative donor transplants for patients with advanced hematologic malignancies, conditioned with thiotepa, cyclophosphamide and antithymocyte globulin

      BONE MARROW TRANSPLANTATION
    33. Gutierrez-Delgado, F; Holmberg, LA; Hooper, H; Appelbaum, FR; Livingston, RB; Maziarz, RT; Weiden, P; Rivkin, S; Montgomery, P; Kawahara, K; Bensinger, W
      High-dose busulfan, melphalan and thiotepa as consolidation for noninflammatory high-risk breast cancer

      BONE MARROW TRANSPLANTATION
    34. Demirer, T; Ilhan, O; Mandel, NM; Arat, M; Gunel, N; Celebi, H; Ustun, C; Akan, H; Demirer, S; Aydintug, S; Uysal, A; Koc, H
      A phase I dose escalation study of high-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation (PBSCT) in patients with solid tumors and hematologic malignancies

      BONE MARROW TRANSPLANTATION
    35. Ahmed, T; Kancherla, R; Qureshi, Z; Mittelman, A; Seiter, K; Mannancheril, A; Puccio, C; Chun, HG; Bar, M; Lipshutz, M; Ali, MF; Goldberg, R; Preti, R; Lake, D; Durrani, H; Farley, T
      High-dose chemotherapy and stem cell transplantation for patients with stage IV breast cancer without clinically evident disease: correlation of CD34(+) selection to clinical outcome

      BONE MARROW TRANSPLANTATION
    36. Genre, D; Viens, P; Gravis, G; Bertucci, F; Cowen, D; Novakovitch, G; Dermeche, S; Chabannon, C; Oziel-Taieb, S; Camerlo, J; Houvenaeghel, G; Jacquemier, J; Maraninchi, D
      Outpatient sequential high dose alkylation with stem cell support for patients with advanced breast cancer: A phase I-II study

      ANTICANCER RESEARCH
    37. van Maanen, MJ; Huitema, ADR; Beijen, JH
      Influence of co-medicated drugs on the biotransformation of thioTEPA to TEPA and thioTEPA-mercapturate

      ANTICANCER RESEARCH
    38. Hawkins, D; Barnett, T; Bensinger, W; Gooley, T; Sanders, E
      Busulfan, melphalan, and thiotepa with or without total marrow irradiationwith hematopoietic stem cell rescue for poor-risk Ewing-sarcoma-family tumors

      MEDICAL AND PEDIATRIC ONCOLOGY
    39. Stadtmauer, EA; O'Neill, A; Goldstein, LJ; Crilley, PA; Mangan, KF; Ingle, JN; Brodsky, I; Martino, S; Lazarus, HM; Erban, JK; Sickles, C; Glick, JH
      Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer.

      NEW ENGLAND JOURNAL OF MEDICINE
    40. Montes, A; Palou, J; Martin, E
      Acute autologous graft-versus-host grade II

      MEDICINA CLINICA
    41. Bouffet, E; Raquin, M; Doz, F; Gentet, JC; Rodary, C; Demeocq, F; Chastagner, P; Lutz, P; Hartmann, O; Kalifa, C
      Radiotherapy followed by high dose busulfan and thiotepa - A prospective assessment of high dose chemotherapy in children with diffuse pontine gliomas

      CANCER
    42. Raiola, AM; Van Lint, MT; Lamparelli, T; Gualandi, F; Mordini, N; Berisso, G; Bregante, S; Frassoni, F; Sessarego, M; Fugazza, G; Di Stefano, F; Pitto, A; Bacigalupo, A
      Reduced intensity thiotepa-cyclophosphamide conditioning for allogeneic haemopoietic stem cell transplants (HSCT) in patients up to 60 years of age

      BRITISH JOURNAL OF HAEMATOLOGY
    43. Patterson, LH; McKeown, SR; Ruparella, K; Double, JA; Bibby, MC; Cole, S; Stratford, IJ
      Enhancement of chemotherapy and radiotherapy of murine tumours by AQ4N, a bioreductively activated anti-tumour agent

      BRITISH JOURNAL OF CANCER
    44. Stiff, P; Chen, BH; Franklin, W; Oldenberg, D; Hsi, E; Bayer, R; Shpall, E; Douville, J; Mandalam, R; Malhotra, D; Muller, T; Armstrong, RD; Smith, A
      Autologous transplantation of ex vivo expanded bone marrow cells grown from small aliquots after high-dose chemotherapy for breast cancer

      BLOOD
    45. van Maanen, MJ; Beijnen, JH
      Liquid chromatographic-mass spectrometric determination of the novel, recently identified thioTEPA metabolite, thioTEPA-mercapturate, in urine

      JOURNAL OF CHROMATOGRAPHY B
    46. Casciano, DA; Aidoo, A; Chen, T; Mittelstaedt, RA; Manjanatha, MG; Heflich, RH
      Hprt mutant frequency and molecular analysis of Hprt mutations in rats treated with mutagenic carcinogens

      MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
    47. Prince, HM; Millward, MJ; Rischin, D; Blakey, D; Francis, P; Gates, P; Chapple, P; Quinn, M; Juneja, S; Wolf, M; Januszewicz, EH; Seymour, JF; Brettell, M; Strickland, A; Zalcberg, J; Richardson, G; Scarlett, J; Briggs, P; Toner, GC
      Repetitive high-dose therapy with ifosfamide, thiotepa and paclitaxel withperipheral blood progenitor cell and filgrastim support for metastatic andlocally advanced breast cancer: Results of a phase I study

      ANNALS OF ONCOLOGY
    48. Rodenhuis, S; de Wit, R; de Mulder, PHM; Keizer, HJ; Sleijfer, DT; Lalisang, RI; Bakker, PJM; Mandjes, I; Kooi, M; de Vries, EGE
      A multi-center prospective phase II study of high-dose chemotherapy in germ-cell cancer patients relapsing from complete remission

      ANNALS OF ONCOLOGY
    49. Kondo, T; Onitsuka, S; Ryoji, O; Kihara, T; Goto, Y; Satoh, T; Nakazawa, H; Toma, H
      Analysis of prognostic factors related to primary superficial bladder cancer tumor recurrence in prophylactic intravesical epirubicin therapy

      INTERNATIONAL JOURNAL OF UROLOGY
    50. van Maanen, MJ; Brandt, AC; Damen, JMA; Beijnen, JH
      Degradation study of thiotepa in aqueous solutions

      INTERNATIONAL JOURNAL OF PHARMACEUTICS
    51. Grossman, SA; Krabak, MJ
      Leptomeningeal carcinomatosis

      CANCER TREATMENT REVIEWS
    52. Feun, LG; Reddy, KR; Scagnelli, T; Yrizarry, JM; Guerra, JJ; Russell, E; Schwartz, M; Savaraj, N; Livingstone, AS; Levi, JU; Jeffers, LJ; Ardalan, B; Schiff, ER
      A phase I study of chemoembolization with cisplatin, thiotepa, and lipiodol for primary and metastatic liver cancer

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    53. Worth, LL; Tran, H; Petropoulos, D; Culbert, SC; Mullen, CA; Roberts, WM; Przepiorka, D; Chan, KW
      Hematopoietic stem cell transplantation for childhood myeloid malignanciesafter high-dose thiotepa, busulfan and cyclophosphamide

      BONE MARROW TRANSPLANTATION
    54. Sica, S; Cicconi, S; Sora, F; Chiusolo, P; Piccirillo, N; Laurenti, L; La Barbera, EO; Giordano, G; Leone, G
      Inappropriate antidiuretic hormone secretion after high-dose thiotepa

      BONE MARROW TRANSPLANTATION
    55. Rosales, F; Peylan-Ramu, N; Cividalli, G; Varadi, G; Or, R; Naparstek, E; Slavin, S; Nagler, A
      The role of thiotepa in allogeneic bone marrow transplantation for geneticdiseases

      BONE MARROW TRANSPLANTATION
    56. Przepiorka, D; Khouri, I; Thall, P; Mehra, R; Lee, MS; Ippoliti, C; Giralt, S; Gajewski, J; van Besien, K; Andersson, B; Korbling, M; Deisseroth, AB; Champlin, R
      Thiotepa, busulfan and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced chronic myelogenous leukemia

      BONE MARROW TRANSPLANTATION
    57. Tassy, A; Ribe, D
      Thiotepa eyedrops to prevent pterygium recurrences. 18 years of utilization

      JOURNAL FRANCAIS D OPHTALMOLOGIE
    58. Rosales, F; Naparstek, E; Varadi, G; Or, R; Slavin, S; Nagler, A
      The role of thiotepa in allogeneic stem cell transplantation in patients with leukemia

      LEUKEMIA RESEARCH
    59. Chen, T; Aidoo, A; Mittelstaedt, RA; Casciano, DA; Heflich, RH
      Hprt mutant frequency and molecular analysis of Hprt mutations in Fischer 344 rats treated with thiotepa

      CARCINOGENESIS
    60. Voloshchuk, TP; Patskovskii, YB; Potopalskii, AI
      Alkylation of nucleic acid components with ethylenimine and its derivatives. IV. Alkylation of homopolynucleotides and DNA

      BIOORGANICHESKAYA KHIMIYA
    61. Rowlings, PA; Williams, SF; Antman, KH; Fields, KK; Fay, JW; Reed, E; Pelz, CJ; Klein, JP; Sobocinski, KA; Kennedy, MJ; Freytes, CO; McCarthy, PL; Herzig, RH; Stadtmauer, EA; Lazarus, HM; Pecora, AL; Bitran, JD; Wolff, SN; Gale, RP; Armitage, JO; Vaughan, WP; Spitzer, G; Horowitz, MM
      Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation for metastatic breast cancer

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    62. Pession, A; Prete, A; Locatelli, F; Bella, S; Melchionda, F; Garaventa, A; Burnelli, R; Paolucci, G
      Phase I study of high-dose thiotepa with busulfan, etoposide, and autologous stem cell support in children with disseminated solid tumors

      MEDICAL AND PEDIATRIC ONCOLOGY
    63. Nitz, U; Mohrmann, S; Bender, HG
      High dose chemotherapy with peripheral blood progenitor support in metastatic breast cancer

      GYNAKOLOGE
    64. Guerrero, A; Perez-Simon, JA; Gutierrez, N; Caballero, D; Ortin, F; Gomez-Sanchez, JC; Cacho, J; San Miguel, JF
      Neurological complications after autologous stem cell transplantation

      EUROPEAN NEUROLOGY
    65. Srivastava, SK; Singhal, SS; Hu, X; Awasthi, YC; Zimniak, P; Singh, SV
      Differential catalytic efficiency of allelic variants of human glutathioneS-transferase Pi in catalyzing the glutathione conjugation of thiotepa

      ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
    66. van Maanen, RJ; van Ooijen, RD; Zwikker, JW; Huitema, ADR; Rodenhuis, S; Beijnen, JH
      Determination of N,N ',N ''-triethylenethiophosphoramide and its active metabolite N,N ',N ''-triethylenephosphoramide in plasma and urine using capillary gas chromatography

      JOURNAL OF CHROMATOGRAPHY B
    67. HUITEMA ADR; TIBBEN MM; KERBUSCH T; ZWIKKER JW; RODENHUIS S; BEIJNEN JH
      SIMULTANEOUS DETERMINATION OF N,N',N''-TRIETHYLENETHIOPHOSPHORAMIDE, CYCLOPHOSPHAMIDE AND SOME OF THEIR METABOLITES IN PLASMA USING CAPILLARY GAS-CHROMATOGRAPHY

      Journal of chromatography B. Biomedical sciences and applications
    68. VASSAL G; BOLAND I; TERRIERLACOMBE MJ; WATSON AJ; MARGISON GP; VENUAT AM; MORIZET J; PARKER F; LACROIX C; LELLOUCHTUBIANA A; PIERREKAHN A; POULLAIN MG; GOUYETTE A
      ACTIVITY OF FOTEMUSTINE IN MEDULLOBLASTOMA AND MALIGNANT GLIOMA XENOGRAFTS IN RELATION TO O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE AND ALKYLPURINE-DNA N-GLYCOSYLASE ACTIVITY

      Clinical cancer research
    69. VASSAL G; BOLAND I; TERRIERLACOMBE MJ; WATSON AJ; MARGISON GP; VENUAT AM; MORIZET J; PARKER F; LACROIX C; LELLOUCHTUBIANA A; PIERREKAHN A; POULLAIN MG; GOUYETTE A
      ACTIVITY OF FOTEMUSTINE IN MEDULLOBLASTOMA AND MALIGNANT GLIOMA XENOGRAFTS IN RELATION TO O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE AND ALKYLPURINE-DNA N-GLYCOSYLASE ACTIVITY

      Clinical cancer research
    70. DAGHER R; KREISSMAN S; ROBERTSON KA; PROVISOR A; BERGSTEIN J; BURKE K; RODMAN JH; EMANUEL D; SMITH FO
      HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION IN AN ANEPHRIC CHILD WITH MULTIPLY RECURRENT WILMS-TUMOR

      Journal of pediatric hematology/oncology
    71. SCHWARTZBERG LS; BIRCH R; WEST WH; TAUER KW; WITTLIN F; LEFF R; CAMPOS L; RYMER W; CARTER P; MANGUM M; GRECO FA; HAINSWORTH J; RAEFSKY E; BLANCO R; BUCKNER CD; WEAVER CH
      SEQUENTIAL TREATMENT INCLUDING HIGH-DOSE CHEMOTHERAPY WITH PERIPHERAL-BLOOD STEM-CELL SUPPORT IN PATIENTS WITH HIGH-RISK STAGE II-III BREAST-CANCER - OUTPATIENT ADMINISTRATION IN COMMUNITY CANCER CENTERS

      American journal of clinical oncology
    72. HOLMBERG LA; DEMIRER T; ROWLEY S; BUCKNER CD; GOODMAN G; MAZIARZ R; KLARNET J; ZUCKERMAN N; HARRER G; MCCLOSKEY R; GERSH R; GOLDBERG R; NICHOLS W; JACOBS A; WEIDEN P; MONTGOMERY P; RIVKIN S; APPELBAUM FR; BENSINGER WI
      HIGH-DOSE BUSULFAN, MELPHALAN AND THIOTEPA FOLLOWED BY AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL (PBSC) RESCUE IN PATIENTS WITH ADVANCED-STAGE III IV OVARIAN-CANCER/

      Bone marrow transplantation
    73. LUCIDARME N; VALTEAUCOUANET D; OBERLIN O; COUANET D; KALIFA C; BEAUJEAN F; LAPIERRE V; HARTMANN O
      PHASE-II STUDY OF HIGH-DOSE THIOTEPA AND HEMATOPOIETIC STEM-CELL TRANSPLANTATION IN CHILDREN WITH SOLID TUMORS

      Bone marrow transplantation
    74. LJUNGMAN P; BJORKSTRAND B; FORNANDER T; HOGLUND M; JULIUSSON G; LINDMAN H; MALMSTROM A; ROTSTEIN S; SODERBERG M; WILKING N; VILLMAN K; BERGH J
      HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM-CELL SUPPORT IN PATIENTS WITH RESPONDING STAGE-IV BREAST-CANCER

      Bone marrow transplantation
    75. HARA J; OSUGI Y; OHTA H; MATSUDA Y; NAKANISHI K; TAKAI K; FUJISAKI H; TOKIMASA S; FUKUZAWA M; OKADA A; OKADA S
      DOUBLE-CONDITIONING REGIMENS CONSISTING OF THIOTEPA, MELPHALAN AND BUSULFAN WITH STEM-CELL RESCUE FOR THE TREATMENT OF PEDIATRIC SOLID TUMORS

      Bone marrow transplantation
    76. BAKER WJ; VUKELJA SJ; LEE N; PERRY JJ
      HIGH-DOSE CYCLOPHOSPHAMIDE, ETOPOSIDE AND CARBOPLATIN WITH AUTOLOGOUSBONE-MARROW SUPPORT FOR METASTATIC BREAST-CANCER - LONG-TERM RESULTS

      Bone marrow transplantation
    77. DOWN JD; WESTERHOF GR; BOUDEWIJN A; SETROIKROMO R; PLOEMACHER RE
      THIOTEPA IMPROVES ALLOGENEIC BONE-MARROW ENGRAFTMENT WITHOUT ENHANCING STEM-CELL DEPLETION IN IRRADIATED MICE

      Bone marrow transplantation
    78. LAPORT GF; GRAD G; GRINBLATT DL; BITRAN JD; WILLIAMS SF
      HIGH-DOSE CHEMOTHERAPY CONSOLIDATION WITH AUTOLOGOUS STEM-CELL RESCUEIN METASTATIC BREAST-CANCER - A 10-YEAR EXPERIENCE

      Bone marrow transplantation
    79. WEAVER CH; MOSS T; SCHWARTZBERG LS; ZHEN B; WEST J; RHINEHART S; CAMPOS L; BEEKER T; LAUTERSZTAIN L; MESSINO M; BUCKNER CD
      HIGH-DOSE CHEMOTHERAPY IN PATIENTS WITH BREAST-CANCER - EVALUATION OFINFUSING PERIPHERAL-BLOOD STEM-CELLS CONTAINING OCCULT TUMOR-CELLS

      Bone marrow transplantation
    80. YEH KH; LIN MT; LIN DT; TANG JL; LUI LT; LIN JF; CHANG YS; CHENG AL; YU SC; CHANG KJ; CHEN YC
      HIGH-DOSE THERAPY WITH PERIPHERAL-BLOOD STEM-CELL (PBSC) SUPPORT USING AN INNOVATIVE MOBILIZATION REGIMEN IN PATIENTS WITH HIGH-RISK PRIMARY OR CHEMORESPONSIVE METASTATIC BREAST CANCERS

      Breast cancer research and treatment
    81. DUNKEL IJ; GARVIN JH; GOLDMAN S; ETTINGER LJ; KAPLAN AM; CAIRO M; LI H; BOYETT JM; FINLAY JL
      HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS BONE-MARROW RESCUE FOR CHILDREN WITH DIFFUSE PONTINE BRAIN-STEM TUMORS

      Journal of neuro-oncology
    82. NAGLER A; FINLANDER R; OR R; NAPARSTEK E; VARADI G; SLAVIN S
      THE ROLE OF THIOTEPA IN AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR ACUTE-LEUKEMIA

      Leukemia research
    83. RODENHUIS S; RICHEL DJ; VANDERWALL E; SCHORNAGEL JH; BAARS JW; KONING CCE; PETERSE JL; BORGER JH; NOOIJEN WJ; BAKX R; DALESIO O; RUTGERS E
      RANDOMIZED TRIAL OF HIGH-DOSE CHEMOTHERAPY AND HEMATOPOIETIC PROGENITOR-CELL SUPPORT IN OPERABLE BREAST-CANCER WITH EXTENSIVE AXILLARY LYMPH-NODE INVOLVEMENT

      Lancet
    84. HUSAIN A; ROSALES N; SCHWARTZ GK; SPRIGGS DR
      LISOFYLLINE SENSITIZES P53 MUTANT HUMAN OVARIAN-CARCINOMA CELLS TO THE CYTOTOXIC EFFECTS OF CIS-DIAMMINEDICHLOROPLATINUM(II)

      Gynecologic oncology (Print)
    85. Feun, LG; Blessing, JA; Major, FJ; DiSaia, PJ; Alvarez, RD; Berek, JS
      A phase II study of intraperitoneal cisplatin and thiotepa in residual ovarian carcinoma. A gynecologic oncology group study

      GYNECOLOGIC ONCOLOGY
    86. VANDAM FSAM; SCHAGEN SB; MULLER MJ; BOOGERD W; VONDERWALL E; FORTUYN MED; RODENHUIS S
      IMPAIRMENT OF COGNITIVE FUNCTION IN WOMEN RECEIVING ADJUVANT TREATMENT FOR HIGH-RISK BREAST-CANCER - HIGH-DOSE VERSUS STANDARD-DOSE CHEMOTHERAPY

      Journal of the National Cancer Institute
    87. BADALAMENT RA; FARAH RN
      TREATMENT OF SUPERFICIAL BLADDER-CANCER WITH INTRAVESICAL CHEMOTHERAPY

      Seminars in surgical oncology
    88. VANMAANEN RJ; VANOOIJEN RD; BEIJNEN JH
      DETERMINATION OF N,N',N''-TRIETHYLENTHIOPHOSPHORAMIDE IN BIOLOGICAL SAMPLES USING CAPILLARY GAS-CHROMATOGRAPHY

      Journal of chromatography B. Biomedical sciences and applications
    89. MURRAY KM; ERKKILA D; GOMBOTZ WR; PANKEY S
      STABILITY OF THIOTEPA (LYOPHILIZED) IN 0.9-PERCENT SODIUM-CHLORIDE INJECTION

      American journal of health-system pharmacy
    90. UCHIDA T; EGAWA S; IWAMURA M; OHKAWA A; ENDO T; KOSHIBA K
      3-DAY INTRAVESICAL INSTILLATION OF ANTICANCER DRUGS FOR PROPHYLAXIS OF BLADDER-CANCER

      Oncology Reports
    91. KRAMER ED; PACKER RJ; GINSBERG J; GOLDMAN S; THOMPSON S; BAYER LA; SHEN V; HARRIS R; KHAN S; FINLAY JL
      ACUTE NEUROLOGIC DYSFUNCTION ASSOCIATED WITH HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW RESCUE FOR PRIMARY MALIGNANT BRAIN-TUMORS

      Pediatric neurosurgery
    92. BALMACEDA C; FETELL MR; HESDORFFER C
      THIOTEPA AND ETOPOSIDE TREATMENT OF RECURRENT MALIGNANT GLIOMAS - PHASE-I STUDY

      Cancer chemotherapy and pharmacology
    93. SASAKI Y
      PHARMACOLOGICAL CONSIDERATIONS IN HIGH-DOSE CHEMOTHERAPY

      Cancer chemotherapy and pharmacology
    94. MARIN D; VALERA R; DELARED E; TEIJEIRO C
      ELECTROCHEMICAL STUDY OF ANTINEOPLASTIC DRUG THIOTEPA HYDROLYSIS TO THIOL FORM AND THIOTEPA-DNA INTERACTIONS

      Bioelectrochemistry and bioenergetics
    95. TALLMAN MS; RADEMAKER AW; JAHNKE L; BROWN SG; BAUMAN A; MANGAN C; KELLY C; RUBIN H; KIES MS; SHAW J; KIEL K; GORDON LI; GRADISHAR WJ; WINTER JN
      HIGH-DOSE CHEMOTHERAPY, AUTOLOGOUS BONE-MARROW OR STEM-CELL TRANSPLANTATION AND POSTTRANSPLANT CONSOLIDATION CHEMOTHERAPY IN PATIENTS WITH ADVANCED BREAST-CANCER

      Bone marrow transplantation
    96. CHAN KW; PETROPOULOS D; CHOROSZY M; HERZOG C; JAFFE N; ATER J; KORBLING M
      HIGH-DOSE SEQUENTIAL CHEMOTHERAPY AND AUTOLOGOUS STEM-CELL REINFUSIONIN ADVANCED PEDIATRIC SOLID TUMORS

      Bone marrow transplantation
    97. TOMAS JF; PEREZCARRION R; ESCUDERO A; LOPEZLORENZO JL; LOPEZPASCUAL J; FERNANDEZRANADA JM
      RESULTS OF A PILOT-STUDY OF 40 PATIENTS USING HIGH-DOSE THERAPY WITH HEMATOPOIETIC RESCUE AFTER STANDARD-DOSE ADJUVANT THERAPY FOR HIGHRISKBREAST-CANCER

      Bone marrow transplantation
    98. DELIMA M; VANBESIEN KW; GIRALT SA; KHOURI IF; MEHRA R; ANDERSSON BS; PRZEPIORKA D; GAJEWSKI JL; KORBLING M; CHAMPLIN RE
      BONE-MARROW TRANSPLANTATION AFTER FAILURE OF AUTOLOGOUS TRANSPLANT FOR NON-HODGKINS-LYMPHOMA

      Bone marrow transplantation
    99. BENSINGER WI; SCHIFFMAN KS; HOLMBERG L; APPELBAUM FR; MAZIARZ R; MONTGOMERY P; ELLIS E; RIVKIN S; WEIDEN P; LILLEBY K; ROWLEY S; PETERSDORF S; KLARNET JP; NICHOLS W; HERTLER A; MCCROSKEY R; WEAVER CH; BUCKNER CD
      HIGH-DOSE BUSULFAN, MELPHALAN, THIOTEPA AND PERIPHERAL-BLOOD STEM-CELL INFUSION FOR THE TREATMENT OF METASTATIC BREAST-CANCER

      Bone marrow transplantation
    100. FONTELONGA A; KELLY AJ; MACKINTOSH FR; HALL S; MONROE P; WILSON GS; SHAFT D; RUTHVEN A; ASCENSAO JL
      A NOVEL HIGH-DOSE CHEMOTHERAPY PROTOCOL WITH AUTOLOGOUS HEMATOPOIETICRESCUE IN PATIENTS WITH METASTATIC BREAST-CANCER OR RECURRENT NON-HODGKINS-LYMPHOMA

      Bone marrow transplantation


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 19/10/20 alle ore 23:53:48